Evidence digest
The published BPC-157 literature is preclinical. It consists of rodent injury models and cell-culture work; there are no controlled human trials in the indexed literature. That is the single most important thing to know about this compound, because vendor copy routinely describes rodent findings in language that implies a human effect. Animal results are a reason to run a human trial, not a substitute for one.
Updated 22 Jul 2026 · 3 studies indexed · no human evidence · compound record
Origin Labs$2.50/mg listed · 1 BPC-157 certificate96.9of 100Extensively documentedVisit Origin Labs
Next Gen Peptides$3.00/mg listed · 6 BPC-157 certificates93.6of 100Extensively documentedVisit Next Gen Peptides
PeptidePlugs$3.00/mg listed · 2 BPC-157 certificates91.3of 100Extensively documentedVisit PeptidePlugsRanked on this compound's price per mg against the market median, with testing and documentation counted as they are overall. What a vial contains is answered by that vendor's certificates, not by the studies below.
| Study | Evidence type | Model | n | What it reported | Source |
|---|---|---|---|---|---|
| Preclinical rodent work on BPC-157 and tendon healingPubMed listing | Animal | Rat, transected Achilles tendon model | — | The listed literature reports outcomes in rodent tendon-injury models. Endpoints are histological and biomechanical measurements in animals; no human endpoint is reported in this body of work. | Listing |
| Preclinical rodent work on BPC-157 in gastrointestinal injury modelsPubMed listing | Animal | Rat, induced gastric lesion model | — | The listed literature reports mucosal outcomes in induced gastrointestinal lesion models in rodents. The originating sequence was identified in gastric juice; the material sold under this name is synthetic. | Listing |
| In vitro work on BPC-157 and fibroblast activityPubMed listing | In vitro | Cultured fibroblasts | — | Cell-culture work examining fibroblast migration and proliferation. In vitro results describe cell behaviour in a dish and do not establish an effect in a living organism of any species. | Listing |
The FDA maintains categorised lists of bulk drug substances nominated for use in compounding, including substances it has evaluated and placed in the category that may not be compounded. Several peptides tracked in this index have appeared in these evaluations. PepIndex records movements between categories here as they are observed; the linked page is the authoritative listing.
The evidence above describes the published literature. What any individual vial contains is a separate question, answered by that vendor’s certificate records rather than by any study on this page.
How to read this page
This digest describes what published research exists and what it does not establish. It is not a recommendation, contains no dosing information or protocols, and makes no claim that any compound is safe or effective for any purpose. Material listed by indexed vendors is labeled for laboratory research use only.
